Abstract
Objectives: Vibrio cholerae O1 from a 2006 outbreak in Accra were commonly resistant to multiple antimicrobials and, in particular, to trimethoprim/sulfamethoxazole, drugs commonly used in the treatment of cholera. We sought to determine the genetic basis for trimethoprim/ sulfamethoxazole resistance in outbreak isolates. Methods: Twenty-seven isolates from the outbreak were screened by PCR and sequencing for class 1 and 2 integrons and for the SXT element. Results: Twenty-one of the 27 isolates examined, all from the Accra metropolitan area, carried both SXT, an integrated chromosomal element, and a class 2 integron bearing dfrA1, sat and aadA1 cassettes. All these isolates had identical random amplification of polymorphic DNA profiles and two of them also carried a class 1 integron. Conclusions: Most strains characterized carried multiple elements conferring resistance to trimethoprim. This suggests that trimethoprim/ sulfamethoxazole should not be used empirically in cholera treatment. © The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Opintan, J. A., Newman, M. J., Nsiah-Poodoh, O. A., & Okeke, I. N. (2008). Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element. Journal of Antimicrobial Chemotherapy, 62(5), 929–933. https://doi.org/10.1093/jac/dkn334
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.